Career in Business and Academia

• President and Representative Partner, GloriaLTH LLC.

  

  2018 - Current

• Steering Science Committee Member of Translational Research Initiative at the University of Tokyo

  

  2013 – Current

• Executive Officer and VP, Business Development and Corporate Strategy, AstraZeneca Japan Co., Ltd.

  

  2021 - 2023

• Managing Executive Officer, Research, Development and BD, Nihon Medi-Physics Co., Ltd.

  

  2020 - 2021

• Sr. VP and Head of Japan, Vaccine Business Unit, Takeda Pharmaceutical Co., Ltd.

  

  2014 – 2018

• Executive Board Member, Japan Association of Vaccine Industries (JAVI)

  

  2014 – 2018

• Senior Corporate Officer and VP, Head of R&D, Sanofi Japan

  

  2012 – 2014

• Chairman of the Board, Kanae Foundation for the Promotion of Medical Science

  

  2012 – 2014

• Sr. VP, Head of Global R&D Japan Hub, CMO and GxP Officer, The Merck Group (Merck Serono) Japan

  

  2009 - 2012

• Executive Director, Clinical Development Service, Quintiles

  

  2007 - 2009

• Senior Director, Head of R&D, Consumer Healthcare, Pfizer

  

  2004 - 2007

• Coca-Cola Enterprises, Director, Applied Research/Basic Research, Coca-Cola Asia Pacific Research and Development Co., Ltd. and Director, Environmental Technical Affairs, Coca-Cola Japan, Co., Ltd.

  

  2001 - 2004

• Director's positions at Eisai group
  Associate Director, Eisai Research Institute of Boston, Inc., US Director of Medicinal Chemistry, Eisai London Research aboratories, Ltd., UK
  Senior Manager, Tsukuba Research Center, Eisai Co. Ltd., Japan

  

  1983 - 2001

• Postdoctoral fellow at Harvard University, Chemistry & Biological Chemistry

  

  1995-1997

• PhD. for Chemistry at University of Tsukuba

  

  1980's - 1990's

• Achievements in Science and Technology, see: https://www.glorialth.com/publication/

  1980's - 2020's